(Washington, DC) – American Idol® winner and platinum selling recording artist David Cook, performing at a benefit concert at Jammin Java in Virginia on December 2nd, celebrated reaching a $1 million fundraising goal for brain cancer research with his fans across the globe.
Since 2009, Cook and his fans had raised $930,000 for brain cancer research through the Race for Hope DC and various other events. In November, Cook set a goal of raising the remaining $70,000 to benefit Accelerate Brain Cancer Cure (ABC2), a venture philanthropy organization. His fans contributed to Cook's campaign on Crowdrise.
Cook has been a champion for brain cancer research since losing his beloved brother Adam to the disease. “It’s one of my proudest life experiences to be involved in this fight.” said Cook, “The way the fans have galvanized around this cause has been huge.”
“Raising a million dollars for brain cancer research is quite an accomplishment,” said Max Wallace, CEO of ABC2, “David and his fans are making a big impact.”
Cook is putting the finishing touches on a new album and the first single, “Wait for Me,” is available on iTunes and other digital retailers.
Cook and his fans will continue fundraising when they participate in the 2015 Race for Hope on May 3, 2022 in Washington, DC, which benefits Accelerate Brain Cancer Cure and the National Brain Tumor Society.
DAVID COOK
David Cook immediately launched to stardom following his Season 7 American Idol® title. A week after his victory, Cook broke several Billboard chart records when 14 of his songs debuted on the Hot Digital Songs chart and 11 of his songs debuted on the Hot 100. Cook’s recording career has spawned chart topping hits, a platinum album and multiple platinum singles. Cook continues to tour throughout the world and his next studio album is set for release in 2015.
ACCELERATE BRAIN CANCER CURE (ABC²)
ABC2 is a venture philanthropy 501(c) (3) nonprofit organization that drives cutting-edge research and treatments for brain tumors. Through strategic partnerships with medical research centers, early-stage biotechnology companies and large multi-national pharmaceutical companies ABC2 has awarded more than $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 42 institutions and companies. Learn more at: www.abc2.org
###
